Global Hemodialysis Vascular Grafts Market Size study & Forecast, by Raw Material (Polytetrafluoroethylene, Polyester, Biological Materials, and Polyurethane), by End-User (Hospitals and Ambulatory Surgical Centers (ASCs)), by Indication (Endovascular Ane

Global Hemodialysis Vascular Grafts Market Size study & Forecast, by Raw Material (Polytetrafluoroethylene, Polyester, Biological Materials, and Polyurethane), by End-User (Hospitals and Ambulatory Surgical Centers (ASCs)), by Indication (Endovascular Aneurysm Repair, Peripheral Vascular Repair, Hemodialysis Access) and Regional Analysis, 2022-2029

Global Hemodialysis Vascular Grafts Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Hemodialysis Vascular Grafts is used as surgical vein which is used to remove or return blood during hemodialysis. The Hemodialysis Vascular Grafts Market is expanding because of factors such as rising prevalence of chronic kidney disease, rising prevalence of renal diseases. However, high cost of hemodialysis vascular graft may halt market growth.

According to a report of the United States Renal Data System (USRDS), as of the year 2021, around 786,000 people in the U.S. are suffering from End-stage kidney disease (ESKD), and this number is projected to reach 886,000 by the year 2030. Thus, rising prevalence of chronic kidney disease is catering to the adoption of hemodialysis vascular grafts. Furthermore, due to several conditions, including hypertension, diabetes, and cardiovascular disease, the chance of getting renal disease also rises as people age. The globe Bank Group estimates that there were 727 million elderly people in the globe in 2020, and that number will triple over the following three decades to reach 1.5 billion by year 2050. Thus rising geriatric population across the globe is catering to market growth. In addition, rising technological advancement is creating lucrative growth in the market.

The key regions considered for the Global Hemodialysis Vascular Grafts Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of product development activities, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:
W. L. Gore & Associates, Inc
C. R. Bard, Inc.,
Vascudyne, Inc.,
LeMaitre
Getinge AB
VASCULAR GENESIS
InnAVasc Medical, Inc.
CryoLife, Inc.
Merit Medical Systems
BIOVIC Sdn Bhd.

Recent Developments in the Market:
In May 2022, Medtronic established a partnership with DaVita. In order to enhance overall outcomes in the field of hemodialysis and patient treatment experiences, the firms announced the foundation of a new, independent medical device company that will be focused on kidney care.




Global Hemodialysis Vascular Grafts Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Raw Material, End-User, Indication, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World





The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Raw Materialofferings of key players.

The detailed segments and sub-segment of the market are explained below:

By Raw Material:
Polytetrafluoroethylene
Polyester
Biological Materials
Polyurethane

By End User:
Hospitals
Ambulatory Surgical Centers (ASCs)

By Indication:
Endovascular Aneurysm Repair
Peripheral Vascular Repair
Hemodialysis Access

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

W. L. Gore & Associates, Inc
C. R. Bard, Inc.,
Vascudyne, Inc.,
LeMaitre
Getinge AB
VASCULAR GENESIS
InnAVasc Medical, Inc.
CryoLife, Inc.
Merit Medical Systems
BIOVIC Sdn Bhd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.